PubMed Health⌕ Search

Biomedical subjects

X Daniel

Publications and source records attributed to X Daniel.

2 recordsLinked to original sources

A novel myb oncogene homologue in Arabidopsis thaliana related to hypersensitive cell death.

A novel myb oncogene homologue (AtMYB30) has been isolated by differential screening of a cDNA library prepared from Xanthomonas campestris pv. campestris (X. campestris)-inoculated Arabidopsis thaliana cells cultured in the presence of cycloheximide. AtMYB30 is a single-copy gene, and the encoded protein contains a MYB domain highly homologous to other plant and animal MYB proteins. Analyses of transcript levels in A. thaliana plants, or in cultured A. thaliana cells infected with either virulent or avirulent strains of the pathogens X. campestris and Pseudomonas syringae pv. tomato, showed that maximal levels of transcription of this gene occurred during the hypersensitive response. Furthermore, in A. thaliana mutants affected in the control of cell death initiation (lsd3, lsd4 and lsd5), constitutive expression or expression in lesion-positive plants was observed, while in suppressors of the mutations lsd5 and lsd4, AtMYB30 transcripts did not accumulate. However, AtMYB30 expression could not be detected in the lsd1 mutant, which was hyper-responsive to cell death initiators and unable to limit the extent of cell death, whatever the environmental conditions. The results presented here suggest a strong correlation between AtMYB30 and genetically controlled cell death, with a role in the initiation of cell death rather than in the limitation of its extent. Our results further indicate that the lsd mutants constitute an appropriate genetic model for studying the role of this gene in hypersensitive cell death, and their relation to different steps of the pathway(s) leading to cell death.

Amino Acid Sequence↗

[Slip casting: design and processing].

With the "In-Ceram" system ceramic constructions are made without any metallic support. The cosmetic ceramic (Vitadur N) is reinforced by an aluminous oxide framework made with a bio-ceramic containing 85% aluminium. The nature of this bio-ceramic and its use provide the originality of this procedure. In order to make this framework, a replica in special porous plaster is made based on the working model. This replica is plunged into a "barbotine" (aluminous oxide grains in suspension in water) which is deposited on the surface. After modeling this paste with a brush, the totality is dehydrated and brought to 1, 100 degrees C for 2 h without. This still fragile calcination is infiltrated by coloured glass. This second thermal treatment is carried out, after dehydration, at 1,080 degrees for 2 to 4 h, still vacuum. The second heating allows the calcination to become coloured and fill in the porosities. The conventional feldspar ceramic is then placed onto this very resistant (more than 580 MPa flexural strength) and exceptionally well adapted framework. This procedure is remarkable regarding the marginal adaptation, the quality of the aesthetic result, its biocompatibility and its ease in positioning. Moreover, the minimal thickness of the aluminium coping is 4/10 mm on the lingual and 3/10 mm for other sides, which therefore do not require any more laboratory work than what is required for making a ceramo-metallic crown. Clinical follow-up over four years allows it to be stated that the mechanical and aesthetic qualities of the procedure permit the making of: single anterior and posterior units which can be made splinted; anterior maxillary small bridges (3 or 4 units) under normal occlusal conditions; posterior small bridges, under favourable occlusal conditions.

Aluminum Oxide↗